Stay updated with breaking news from Patrick Perez. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Issuer: CureVac / Key word(s): Study28.05.2024 / 13:00 CET/CESTThe issuer is solely responsible for the content of this announcement.CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK Phase 2 study to assess updated formulations for im...
Issuer: CureVac / Key word: Quarter Results CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update 23.05.2024 / 13:00...
Investegate announcements from EQS-News: CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update
Organizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year endU.S. FDA Fast Track designation granted for pre-pandemic avian influenza (H5N1) vaccine
Investegate announcements from EQS-News: CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK